
In January 2002, the Food and Drug Administration approved the Er,Cr, YSGG laser for complete endodontic therapy.The author presents a case of a 45-year-old male requiring interceptive endodontic therapy of tooth #21 for the fabrication of an overdenture. The YSGG laser was used for access, debridement, and shaping of the canal.The YSGG laser is the first-ever approved by the FDA for complete endodontic therapy. Laser therapy may provide clinical improvements in pain control and disinfection during endodontic therapy.
Chromium, Male, Cuspid, United States Food and Drug Administration, Lasers, Device Approval, Humans, Middle Aged, Root Canal Preparation, United States, Erbium
Chromium, Male, Cuspid, United States Food and Drug Administration, Lasers, Device Approval, Humans, Middle Aged, Root Canal Preparation, United States, Erbium
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
